Share the post "KOBO BIOTECH announced Financial Results Q1 2024-25"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Profit over the Year and quarter: Significant improvement in profitability for KOBO BIOTECH LIMITED. Notable increase of 8.48 % in net profit Year to Year, KOBO BIOTECH LIMITED’s profitability increased by 5.89 % in this quarter.
- EPS over the Year and quarter: EPS increased by 5.66 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Expenses | Rs. 0.23 Cr | Rs. 0.25 Cr | Rs. 0.34 Cr | + 36 % | + 47.83 % |
| Operating Profit | Rs. -0.23 Cr | Rs. -0.25 Cr | Rs. -0.34 Cr | -36 % | -47.83 % |
| OPM % | 0 % | 0 % | 0 % | 0 % | 0 % |
| Other Income | Rs. 0.015 Cr | Rs. 0 Cr | Rs. 0.024 Cr | 0 % | + 60 % |
| Interest | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Depreciation | Rs. 1.01 Cr | Rs. 1.01 Cr | Rs. 1.01 Cr | + 0 % | + 0 % |
| Profit before tax | Rs. -1.23 Cr | Rs. -1.26 Cr | Rs. -1.33 Cr | -5.56 % | -8.13 % |
| Tax % | -0 % | -0 % | -0 % | 0 % | 0 % |
| Net Profit | Rs. -1.23 Cr | Rs. -1.26 Cr | Rs. -1.33 Cr | -5.56 % | -8.13 % |
| EPS in Rs | Rs. 0 | Rs. -0.53 | Rs. -0.56 | -5.66 % | 0 % |
Today, we’re looking at KOBO BIOTECH LIMITED’s financial performance for the Q1(Jun 2024).Expenses ticked up slightly by 36 % quarter-on-quarter, aligning with the annual rise of 47.83 %. Operating profit, while down -47.83 % compared to last year, faced a quarter-on-quarter dip of -36 %, signaling a short-term contraction in margins.
despite an annual growth of 60 %. Depreciation costs climbed by 0 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 0 %. Profit before tax declined annually by -8.13 % but saw a reduction from the preceding quarter by -5.56 %.
Net profit fell by -8.13 % year-on-year but witnessed a -5.56 % contraction from the last quarter. but a quarterly fall of -5.66 %. In summary, KOBO BIOTECH LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Expenses | Rs. 0.23 Cr | Rs. 0.25 Cr | Rs. 0.34 Cr | + 36 % | + 47.83 % |
| Operating Profit | Rs. -0.23 Cr | Rs. -0.25 Cr | Rs. -0.34 Cr | -36 % | -47.83 % |
| Net Profit | Rs. -1.23 Cr | Rs. -1.26 Cr | Rs. -1.33 Cr | -5.56 % | -8.13 % |
| EPS in Rs | Rs. 0 | Rs. -0.53 | Rs. -0.56 | -5.66 % | 0 % |
In reviewing KOBO BIOTECH LIMITED’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Expenses rose by 47.83 % compared to the previous year, with a 36 % increase quarter-on-quarter. Operating Profit dropped by -47.83 % annually, and saw a -36 % decrease from the last quarter.
Net Profit showed yearly decrease of -8.13 %, and experienced a -5.56 % decrease from the previous quarter. however dipped by -5.66 % compared to the last quarter. In essence, while KOBO BIOTECH LIMITED faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
[my_shortcode1 values=”KOBO BIOTECH “]
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/shareholding/20512985.jpg)
